NeoGenomics: Q1 Earnings Snapshot
FacebookTwitterEmail
FORT MYERS, Fla. (AP) NeoGenomics Inc. (NEO) on Wednesday reported a loss of $22.1 million in its first quarter.
On a per-share basis, the Fort Myers, Florida-based company said it had a loss of 19 cents. Losses, adjusted for non-recurring costs and stock option expense, were 4 cents per share.
The results did not meet Wall Street expectations. The average estimate of four analysts surveyed by Zacks Investment Research was for earnings of 1 cent per share.
The operator of cancer-focused testing laboratories posted revenue of $115.5 million in the period, exceeding Street forecasts. Four analysts surveyed by Zacks expected $112.6 million.